These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 433728)

  • 1. Methotrexate for psoriasis-revisited.
    O'Donoghue MN; Melcher RE
    Am Fam Physician; 1979 Apr; 19(4):99-102. PubMed ID: 433728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate in psoriatic arthritis.
    Singh YN; Verma KK; Kumar A; Malaviya AN
    J Assoc Physicians India; 1994 Nov; 42(11):860-2. PubMed ID: 7868484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of severe psoriasis. A national survey.
    Peckham PE; Weinstein GD; McCullough JL
    Arch Dermatol; 1987 Oct; 123(10):1303-7. PubMed ID: 3662561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry.
    Nast A; Reytan N; Rosumeck S; Erdmann R; Rzany B
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1337-42. PubMed ID: 18624864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
    Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
    Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan.
    Feldman SR; Evans C; Russell MW
    J Dermatolog Treat; 2005 Feb; 16(1):37-42. PubMed ID: 15897166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Our experience of psoriatic arthritis and psoriasis treatment with methotrexate (author's transl)].
    Zbojanová M; Vlcek F; Trnavský K
    Cesk Dermatol; 1980 Feb; 55(1):39-44. PubMed ID: 6988086
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of RePUVA and aromatic retinoid Ro 10-9359 with methotrexate in severe forms of psoriasis].
    Mashkilleysson AL; Mashkilleysson NA
    Hautarzt; 1983 May; 34(5):229-30. PubMed ID: 6862887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Photochemotherapy for psoriatic patients treated with corticosteroids and methotrexate].
    Gschnait F; Konrad K; Hönigsmann H; Wolff K
    Hautarzt; 1977 Dec; 28(12):632-7. PubMed ID: 599023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
    Sukarovska BG; Lipozencić J; Vrzogić P
    Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alpha 1-fetoprotein--a marker of potential PUVA side-effects in psoriasis?].
    Wollina U; Schulze M; Schaarschmidt H; Barta U; Pfeiffer L; Knopf B; Horn A
    Z Hautkr; 1985 Mar; 60(6):527-30. PubMed ID: 2581382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of severe psoriasis: about 50 cases].
    Daoud L; Dhaoui MR; Youssef S; Jaber K; Doss N
    Tunis Med; 2007 Oct; 85(10):849-56. PubMed ID: 18236807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
    Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate-induced cirrhosis requiring liver transplantation in three patients with psoriasis. A word of caution in light of the expanding use of this 'steroid-sparing' agent.
    Gilbert SC; Klintmalm G; Menter A; Silverman A
    Arch Intern Med; 1990 Apr; 150(4):889-91. PubMed ID: 2327848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The coexistence of systemic lupus erythematosus and psoriatic arthritis].
    Ohmoto A; Taneichi K; Chimoto T; Konno T; Shibaki H
    Ryumachi; 1986 Aug; 26(4):278-83. PubMed ID: 3563728
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative study of the effect of the antimetabolic agent methotrexate in psoriasis, psoriatic arthropathy and rheumatoid arthritis].
    Siegmeth W; Eberl R; Tausch G; Raith W
    Verh Dtsch Ges Rheumatol; 1969; 1():383-7. PubMed ID: 5403653
    [No Abstract]   [Full Text] [Related]  

  • 18. [Methotrexate therapy in psoriasis].
    Bournerias I
    Rev Prat; 2004 Jan; 54(1):52-5. PubMed ID: 15049601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The unmet treatment need for moderate to severe psoriasis: results of a survey and chart review.
    Christophers E; Griffiths CE; Gaitanis G; van de Kerkhof P
    J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):921-5. PubMed ID: 16922938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term maintenance treatment of moderate-to-severe plaque psoriasis with infliximab in combination with methotrexate or azathioprine in a retrospective cohort.
    Dalaker M; Bonesrønning JH
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):277-82. PubMed ID: 19207642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.